Markets
Monday, October 5, 2026
The Company Chronicle

NYSE · traded in Congress

Novartis AG NVS

$141.8317 +0.8317 (+0.59%) Oct 5, 2026 4:28 AM ET

Market value$270.6B
P/E ratio-
Analyst target$147.00
52-week range-
Avg volume1,763,685
Dividend yield-

Chart

Congress trades in NVS

Members of Congress disclosed 1 transaction in NVS in the filings we have processed.

TradedMemberTypeAmountFiled
08/27/2026 Kevin Hern OK01 Sale $15,001 - $50,000 9/25/2026 filing

Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›

Other companies

Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.

Business Spotlight

Want us to publish your business?

Our team writes and publishes articles about your business on The Company Chronicle every month, with a link to your website. Plans from $30 a month, cancel anytime.

Publish with us